ExsoMed was granted FDA 510(k) clearance for its Four Corner Fusion System to treat wrist arthritis. The company plans to sell this asset to stay focused on its sterile-packed, single-use business model.
Four Corner Fusion will provide surgeons with a solution that requires less reaming, less “drill and fill,” no lunate impingement and preservation of cartilage.
“ExsoMed is thrilled to have partnered with some of hand surgery’s brightest minds to develop this innovative Four Corner Fusion plating system,” said William E. Maya, ExsoMed’s Chief Executive Officer. “We believe the product brings significant advancement to what is often a difficult procedure with poor outcomes.”
ExsoMed was granted FDA 510(k) clearance for its Four Corner Fusion System to treat wrist arthritis. The company plans to sell this asset to stay focused on its sterile-packed, single-use business model.
Four Corner Fusion will provide surgeons with a solution that requires less reaming, less “drill and fill,” no lunate impingement and...
ExsoMed was granted FDA 510(k) clearance for its Four Corner Fusion System to treat wrist arthritis. The company plans to sell this asset to stay focused on its sterile-packed, single-use business model.
Four Corner Fusion will provide surgeons with a solution that requires less reaming, less “drill and fill,” no lunate impingement and preservation of cartilage.
“ExsoMed is thrilled to have partnered with some of hand surgery’s brightest minds to develop this innovative Four Corner Fusion plating system,” said William E. Maya, ExsoMed’s Chief Executive Officer. “We believe the product brings significant advancement to what is often a difficult procedure with poor outcomes.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
